Company intelligence / Profile preview

LuxMed Systems

Cambridge/Boston area, Massachusetts, United Statesluxmedsystems.com ↗

Ownership: Private
Development stage: Clinical

Overview

LuxMed Systems has developed proprietary light-guided radiofrequency and sensor-based pulsed field ablation catheters for cardiac electrophysiology procedures. Their technology enables real-time lesion creation and detection during cardiac catheter ablation, aiming to improve outcomes in the treatment of arrhythmias such as atrial fibrillation. The system allows simultaneous lesion creation with gap detection, potentially reducing procedure times and repeat interventions.

Therapeutic areas: Cardiovascular
Modalities: DeviceRadiofrequency ablation devicePulsed field ablation device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on LuxMed Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LuxMed Systems.

Explore the full profile